Молекулярные маркеры диагностики сердечной недостаточности

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Unknown venue

• Publication date

  2018-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.17116/CARDIOBULLETIN20181304162
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Supression of tumorogenicity 2 significance in patients with heart failure decompensation

  2017cited by this paper
• [Therapy of High Risk Patients After Decompensation of Heart Failure Under NT-proBNP Control. Main Results].

  2016cited by this paper
• Pathophysiology of Heart Failure.

  2015cited by this paper
• A rapid and cost-effective method of producing recombinant proBNP and NT-proBNP variants in Escherichia coli for immunoassay of heart failure

  2013cited by this paper
• Use of procalcitonin for the diagnosis of pneumonia in patients presenting with a chief complaint of dyspnoea: results from the BACH (Biomarkers in Acute Heart Failure) trial

  2012cited by this paper
• [Galectin 3--a new biomarker for diagnostics and outcome of chronic heart failure].

  2012cited by this paper
• Brain natriuretic peptide-guided therapy in the inpatient management of decompensated heart failure

  2012cited by this paper
• Galectin-3 and the development of heart failure after acute coronary syndrome: pilot experience from PROVE IT-TIMI 22.

  2012cited by this paper
• Prognostic value of mid-regional pro-adrenomedullin in patients with heart failure after an acute myocardial infarction

  2011cited by this paper
• Serial changes in high‐sensitive troponin I predict outcome in patients with decompensated heart failure

  2011cited by this paper
• Prognostic utility of plasma neutrophil gelatinase-associated lipocalin in patients with acute heart failure: The NGAL EvaLuation Along with B-type NaTriuretic Peptide in acutely decompensated heart failure (GALLANT) trial

  2011cited by this paper
• Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial.

  2010cited by this paper
• Serum neutrophil gelatinase-associated lipocalin (NGAL) in predicting worsening renal function in acute decompensated heart failure.

  2010cited by this paper
• Assessment of conventional cardiovascular risk factors and multiple biomarkers for the prediction of incident heart failure and atrial fibrillation.

  2010cited by this paper
• Myocardial Ischemia in Patients with Diastolic Dysfunction and Heart Failure

  2010cited by this paper
• Growth differentiation factor 15 in different stages of heart failure: potential screening implications

  2010cited by this paper
• Processing of pro-B-type natriuretic peptide: furin and corin as candidate convertases.

  2010cited by this paper
• Comparison of midregional pro-atrial and B-type natriuretic peptides in chronic heart failure: influencing factors, detection of left ventricular systolic dysfunction, and prediction of death.

  2009cited by this paper
• Molecular forms of natriuretic peptides in heart failure and their implications

  2009cited by this paper
• The additive value of N-terminal pro-B-type natriuretic peptide testing at the emergency department in patients with acute dyspnoea.

  2009cited by this paper
• Profiles of serial changes in cardiac troponin T concentrations and outcome in ambulatory patients with chronic heart failure.

  2009cited by this paper
• Pro-B-type natriuretic peptide levels in acute decompensated heart failure.

  2008cited by this paper
• State of the art: Using natriuretic peptide levels in clinical practice

  2008cited by this paper
• Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.

  2007cited by this paper
• IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system.

  2007cited by this paper
• Clinical epidemiology of heart failure

  2007cited by this paper
• Measurement of the interleukin family member ST2 in patients with acute dyspnea: results from the PRIDE (Pro-Brain Natriuretic Peptide Investigation of Dyspnea in the Emergency Department) study.

  2007cited by this paper
• How obesity affects the cut-points for B-type natriuretic peptide in the diagnosis of acute heart failure. Results from the Breathing Not Properly Multinational Study.

  2006cited by this paper
• GDF15, a Cardioprotective TGF-β Superfamily Protein

  2006cited by this paper
• Altered cardiac myocyte Ca regulation in heart failure.

  2006cited by this paper
• Myocyte apoptosis in heart failure.

  2005cited by this paper
• Diagnostic accuracy of B type natriuretic peptide and amino terminal proBNP in the emergency diagnosis of heart failure

  2005cited by this paper
• Strategies for developing biomarkers of heart failure.

  2004cited by this paper
• Myocyte hypertrophy and apoptosis: a balancing act.

  2004cited by this paper
• Clinical applications of B-type natriuretic peptide (BNP) testing.

  2003cited by this paper
• Expression and Regulation of ST2, an Interleukin-1 Receptor Family Member, in Cardiomyocytes and Myocardial Infarction

  2002cited by this paper
• Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial. Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan.

  2002cited by this paper
• Regulation of cardiac adrenomedullin in heart failure.

  2001cited by this paper
• Characterization of Growth-Differentiation Factor 15, a Transforming Growth Factor β Superfamily Member Induced following Liver Injury

  2000cited by this paper
• Neutrophil Gelatinase-associated Lipocalin in Normal and Neoplastic Human Tissues. Cell Type-specific Pattern of Expression

  1999cited by this paper
• Prospective study of aetiology and outcome of adult lower-respiratory-tract infections in the community.

  1993cited by this paper
• Molecular biology and biochemistry of the natriuretic peptide system. II: Natriuretic peptide receptors.

  1992cited by this paper
• Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide.

  1991cited by this paper
• A new natriuretic peptide in porcine brain

  1988cited by this paper
• Diabetes and cardiovascular disease. The Framingham study.

  1979cited by this paper
• Vascular Health and Risk Management Dovepress the Utility of Troponin Measurement to Detect Myocardial Infarction: Review of the Current Findings

  year unknowncited by this paper

• No citing papers are available for this paper.